Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US DEA reschedules GW Pharmaceuticals’ Epidiolex to Schedule V
Image: Anti-Epilepsy drug EPIDIOLEX has been transferred to Schedule V restriction classification by DEA. Photo: courtesy of Stuart Miles/FreeDigitalPhotos.net.
Image: Anti-Epilepsy drug EPIDIOLEX has been transferred to Schedule V restriction classification by DEA. Photo: courtesy of Stuart Miles/FreeDigitalPhotos.net.